|
|
|
Vaccinex Inc 
|
2.45 -0.25 (-0.09%) |
01-27 16:00 |
Open: |
2.7 |
Pre close: |
2.7 |
Target:
|
3.33
|
High: |
2.75 |
Low: |
2.38 |
Resistance:
|
2.85
3.33
|
Volume: |
569,975 |
Market Cap: |
55M |
Support:
|
2.31
1.98
|
|
|
|
Technical Analysis |
Moving Averages |
MA(5):
|
2.63
 |
MACD |
MACD(12,26):
|
0.13  |
MA(20): |
2.38  |
Signal(12,26,9): |
0.11  |
MA(100): |
2.45  |
Stochastic Oscillator |
%K(14,3):
|
72.26  |
MA(250): |
3.83  |
%D(3): |
77.23  |
Average Volume(K) |
3-Month: |
65027
|
52-Week |
High:
|
9.40 |
10-Days: |
55373 |
Low: |
1.63 |
RSI |
RSI(14):
|
52.54  |
Change(%): |
-67.3 |
Financials, Statistics and Valuation |
EPS |
-1.702 |
Return on Equity (ttm) |
-748.4 |
Shares Out. (M) |
22.39 |
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-121.0 |
Shares Float (M) |
9.19 |
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
18.40 |
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
54.7 |
% Held by Institutions |
50.40 |
Forward EPS |
-5.650 |
Gross Profit (p.s.) |
0.014 |
Shares Short (K) |
257 |
Book Value (p.s.) |
-0.900 |
EBITDA (p.s.) |
-1.263 |
P/E |
-1.44 |
Sales Per Share |
0.028 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-2.72 |
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-28.07 |
P/S |
87.77 |
Operating Margin |
-4572.96 |
Levered Free Cash Flow
(M) |
-17.52 |
P/CF |
-1.95 |
|
|
|
|
|